Akèy › Kansè fwa (Kasinòm epatoselilè)
Etid klinik pou Kansè fwa (Kasinòm epatoselilè) ap rekrite nan Etazini
131 etid pou Kansè fwa (Kasinòm epatoselilè) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX31 etid
- New York City, NY24 etid
- Dallas, TX19 etid
- Los Angeles, CA19 etid
- Boston, MA18 etid
- Cleveland, OH18 etid
- Chicago, IL16 etid
- Philadelphia, PA16 etid
- Pittsburgh, PA15 etid
- San Francisco, CA14 etid
- Orange, CA14 etid
- Jacksonville, FL14 etid
- San Antonio, TX13 etid
- St. Louis, MO13 etid
- Rochester, MN12 etid
- Detroit, MI11 etid
- Portland, OR11 etid
- Baltimore, MD11 etid
- Atlanta, GA11 etid
- Seattle, WA10 etid
- Nashville, TN10 etid
- Mountain View, CA10 etid
- Washington, DC10 etid
- Arlington, VA9 etid
- Baldwin Park, CA9 etid
- Ann Arbor, MI9 etid
- Birmingham, AL8 etid
- Durham, NC8 etid
- Milwaukee, WI8 etid
- Santa Monica, CA8 etid
- San Diego, CA8 etid
- Scottsdale, AZ7 etid
- Phoenix, AZ7 etid
- Omaha, NE7 etid
- Miami, FL7 etid
- Tampa, FL7 etid
- Irvine, CA6 etid
- New Haven, CT6 etid
- Tucson, AZ6 etid
- Aurora, CO6 etid
Pa eta
- Alabama9 etid
- Arizona17 etid
- Ayiti3 etid
- Colorado11 etid
- Connecticut8 etid
- Delaware3 etid
- Distrik Columbia4 etid
- Florid27 etid
- Georgia12 etid
- Illinois20 etid
- Indiana5 etid
- Iowa3 etid
- Kalifòni54 etid
- Kentucky6 etid
- Lwizyàn5 etid
- Maryland16 etid
- Massachusetts19 etid
- Michigan20 etid
- Minnesota21 etid
- Missouri14 etid
- Nebraska8 etid
- Nevada4 etid
- New Hampshire3 etid
- New Jersey10 etid
- New York33 etid
- North Carolina11 etid
- Ohio23 etid
- Oklahoma5 etid
- Oregon11 etid
- Pennsylvania27 etid
- Rhode Island3 etid
- South Carolina6 etid
- Tennessee14 etid
- Texas50 etid
- Utah5 etid
- Virginia17 etid
- Washington15 etid
- Wisconsin12 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
The Vanguard Study: Testing a New Way to Screen for Cancer
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07164313Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03942328Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06726161Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07227012National Liver Cancer Screening Trial
Ap rekriteFaz 4
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07291076Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06915753Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT07219459A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Ap rekriteFaz 1 bonè
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT07627191A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824583A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06427941Defining the Ablative Dose for Y-90 TARE
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07586046A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06007846Evaluating Novel Therapies in ctDNA Positive GI Cancers
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05482516Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04380545Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04864054Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06526338Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06811116Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.